Key result
Implantation of a transvenous magnetic tip lead system in 14 patients resulted in no pacing failures or acute lead dislodgements during the first 30 days.
Why the study?
Does a transvenous magnetic tip lead system prevent pacing failure and lead dislodgement in patients requiring permanent pacing?
Does a transvenous magnetic tip lead system prevent pacing failure and lead dislodgement in patients requiring permanent pacing?
A transvenous magnetic tip lead system appears safe and feasible for permanent ventricular pacing without acute dislodgement in a preliminary 30-day study.
Initial experience supports feasibility of magnetic tip leads; leaves open long-term efficacy versus standard systems in larger trials.
An electrode for transvenous permanent ventricular pacing equipped with a supermagnet was implanted in six dogs in the apex of the right ventricle for several weeks. As no signs of myocardial perforation occurred, the device which consists of the magnetic tip lead and an external supermagnet applied to the precordial region of the chest wall was implanted in 14 patients. The lead was introduced through the right cephalic vein in 12 patients and through the right external jugular vein in the remaining 2 patients. Threshold values were measured twice a day in 12 patients who received a Siemens-Elema Vario pacemaker 629. The average peak threshold was reached on the 11th day after implantation. No pacing failure or other signs of acute dislodgement of leads occurred during the first 30 days.
No takes yet. Share an insight, caveat, or question.
Holen et al. (1980) studied Permanent pacing of the heart (n=14). Transvenous magnetic tip lead system was evaluated on Pacing failure or acute dislodgement of leads. Implantation of a transvenous magnetic tip lead system in 14 patients resulted in no pacing failures or acute lead dislodgements during the first 30 days.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: